Your browser doesn't support javascript.
loading
A Novel Doxorubicin Prodrug with GRP78 Recognition and Nucleus-Targeting Ability for Safe and Effective Cancer Therapy.
Ding, Guo-Bin; Sun, Junqing; Yang, Peng; Li, Binchun; Gao, Ying; Li, Zhuoyu.
Afiliación
  • Ding GB; Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University , Taiyuan 030006, China.
  • Sun J; Institutes of Biomedical Sciences, Shanxi University , Taiyuan 030006, China.
  • Yang P; Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University , Taiyuan 030006, China.
  • Li B; Institutes of Biomedical Sciences, Shanxi University , Taiyuan 030006, China.
  • Gao Y; Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Shanxi University , Taiyuan 030006, China.
  • Li Z; Institutes of Biomedical Sciences, Shanxi University , Taiyuan 030006, China.
Mol Pharm ; 15(1): 238-246, 2018 01 02.
Article en En | MEDLINE | ID: mdl-29207873
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Profármacos / Doxorrubicina / Proteínas de Choque Térmico Límite: Animals / Humans / Male Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Profármacos / Doxorrubicina / Proteínas de Choque Térmico Límite: Animals / Humans / Male Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China